About
Cold-Fx is a product derived from the roots of North American ginseng. It was formulated by Jacqueline Shan, and originally manufactured by her company, Afexa Life Sciences. Afexa was acquired by Valeant Pharmaceuticals in 2011. Bausch & Lomb, acquired by Valeant, is the marketing company for Cold-Fx, as of 2025. There is little evidence to support that Cold-Fx is effective in the common cold. All trials have been done by the manufacturer and there has been poor data reporting. According to Health Canada's Natural Health Product Directorate records, the company claims that it may "help reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system". Cold-Fx is licensed by Health Canada as a natural health product. Read more
Branded Content Partners
Contact
Upgrade to premium to see contact details.Engagement
Coming soon
Audience
Coming soon